标题
Pathogenesis of human cytomegalovirus in the immunocompromised host
作者
关键词
-
出版物
NATURE REVIEWS MICROBIOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-24
DOI
10.1038/s41579-021-00582-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus
- (2021) Virginia-Maria Vlahava et al. JOURNAL OF CLINICAL INVESTIGATION
- Association of donor and recipient cytomegalovirus serostatus on graft and patient survival in liver transplant recipients
- (2021) Philip Vutien et al. LIVER TRANSPLANTATION
- Presence of asymptomatic CMV and EBV DNA in blood of persons with HIV starting antiretroviral therapy are associated with non-AIDS clinical events
- (2020) Sara Gianella et al. AIDS
- The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccination
- (2020) Paul Griffiths ANTIVIRAL RESEARCH
- Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors
- (2020) Nina Singh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus
- (2020) Michael Schwendinger et al. JOURNAL OF INFECTIOUS DISEASES
- Donor cytomegalovirus transmission patterns in solid organ transplant recipients with primary infection
- (2020) Maria E Hasing et al. JOURNAL OF INFECTIOUS DISEASES
- Why the elderly appear to be more severely affected by COVID ‐19: The potential role of immunosenescence and CMV
- (2020) Seilesh Kadambari et al. REVIEWS IN MEDICAL VIROLOGY
- Whole-Genome Approach to Assessing Human Cytomegalovirus Dynamics in Transplant Patients Undergoing Antiviral Therapy
- (2020) Nicolás M. Suárez et al. Frontiers in Cellular and Infection Microbiology
- Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis
- (2019) Mohamed Zuhair et al. REVIEWS IN MEDICAL VIROLOGY
- OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism
- (2019) Xiaofei E et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Generation, maintenance and tissue distribution of T cell responses to human cytomegalovirus in lytic and latent infection
- (2019) Sarah E. Jackson et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
- (2019) Theresa Kaeuferle et al. Journal of Hematology & Oncology
- A prospective multicenter observational study of cell‐mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients
- (2019) Deepali Kumar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis
- (2019) Ajit P Limaye et al. JOURNAL OF INFECTIOUS DISEASES
- A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-Seropositive Recipients of Allogeneic Hematopoietic-Cell Transplantation
- (2019) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene Loss
- (2019) Nicolás M Suárez et al. JOURNAL OF INFECTIOUS DISEASES
- Choice of Study Populations for Vaccines
- (2019) Paul Griffiths et al. JOURNAL OF INFECTIOUS DISEASES
- Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis
- (2018) Xi Li et al. BMC INFECTIOUS DISEASES
- Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia
- (2018) Ilona Baraniak et al. JOURNAL OF INFECTIOUS DISEASES
- The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
- (2018) Camille N. Kotton et al. TRANSPLANTATION
- CD147 Promotes Entry of Pentamer-Expressing Human Cytomegalovirus into Epithelial and Endothelial Cells
- (2018) Adam L. Vanarsdall et al. mBio
- An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor
- (2018) Nadia Martinez-Martin et al. CELL
- Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
- (2018) Genovefa A Papanicolaou et al. CLINICAL INFECTIOUS DISEASES
- HCMV-Encoded NK Modulators: Lessons From in vitro and in vivo Genetic Variation
- (2018) Mihil Patel et al. Frontiers in Immunology
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
- (2018) Francisco M. Marty et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness
- (2017) Ajit P. Limaye et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients
- (2017) Yupin Tong et al. JOURNAL OF INFECTIOUS DISEASES
- Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia
- (2017) Michael Boeckh et al. JOURNAL OF INFECTIOUS DISEASES
- Characterization of Human Cytomegalovirus Genome Diversity in Immunocompromised Hosts by Whole-Genome Sequencing Directly From Clinical Specimens
- (2017) Elias Hage et al. JOURNAL OF INFECTIOUS DISEASES
- Transient Oral Human Cytomegalovirus Infections Indicate Inefficient Viral Spread from Very Few Initially Infected Cells
- (2017) Bryan T. Mayer et al. JOURNAL OF VIROLOGY
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Criteria to define interruption of transmission of human cytomegalovirus from organ donor to recipient
- (2017) Ilona Anna Baraniak et al. REVIEWS IN MEDICAL VIROLOGY
- Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation
- (2017) Ceri A Fielding et al. eLife
- Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells
- (2017) Sarah E. Jackson et al. Frontiers in Immunology
- Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
- (2016) Julie H. Ishida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
- (2016) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- A new perspective of the structural complexity of HCMV-specific T-cell responses
- (2016) Andrew Sylwester et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants
- (2016) E. Panagou et al. Transplant Infectious Disease
- Human Cytomegalovirus Latency: Approaching the Gordian Knot
- (2016) Felicia Goodrum Annual Review of Virology
- Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy
- (2016) Paul D. Griffiths et al. PLoS One
- High-Throughput Analysis of Human Cytomegalovirus Genome Diversity Highlights the Widespread Occurrence of Gene-Disrupting Mutations and Pervasive Recombination
- (2015) Steven Sijmons et al. JOURNAL OF VIROLOGY
- Sepsis and cytomegalovirus: foes or conspirators?
- (2015) Sara Mansfield et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Limits and patterns of cytomegalovirus genomic diversity in humans
- (2015) Nicholas Renzette et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytomegalovirus latency and reactivation: recent insights into an age old problem
- (2015) Liane Dupont et al. REVIEWS IN MEDICAL VIROLOGY
- Crystal Structure of the Human Cytomegalovirus Glycoprotein B
- (2015) Heidi G. Burke et al. PLoS Pathogens
- Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients
- (2014) E. Van Damme et al. JOURNAL OF GENERAL VIROLOGY
- Diverse Specificities, Phenotypes, and Antiviral Activities of Cytomegalovirus-Specific CD8+ T Cells
- (2014) S. E. Jackson et al. JOURNAL OF VIROLOGY
- Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
- (2014) Roy F. Chemaly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients
- (2014) Elisa Gabanti et al. PLoS One
- Seropositivity and Higher Immunoglobulin G Antibody Levels Against Cytomegalovirus Are Associated With Mortality in the Population-Based European Prospective Investigation of Cancer–Norfolk Cohort
- (2013) Effrossyni Gkrania-Klotsas et al. CLINICAL INFECTIOUS DISEASES
- Complex Correlates of Protection After Vaccination
- (2013) S. A. Plotkin CLINICAL INFECTIOUS DISEASES
- CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
- (2013) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Seroprevalence of Cytomegalovirus, Epstein Barr Virus and Varicella Zoster Virus among Pregnant Women in Bradford: A Cohort Study
- (2013) Lucy Pembrey et al. PLoS One
- Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
- (2012) S. F. Atabani et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2012) Mohamed A Kharfan-Dabaja et al. LANCET INFECTIOUS DISEASES
- Decoding Human Cytomegalovirus
- (2012) N. Stern-Ginossar et al. SCIENCE
- Human Cytomegalovirus Encoded Homologs of Cytokines, Chemokines and their Receptors: Roles in Immunomodulation
- (2012) Brian McSharry et al. Viruses-Basel
- Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
- (2011) Per Ljungman et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
- (2011) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibition of Inflammatory Interleukin-6 Activity via Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase Signaling Antagonizes Human Cytomegalovirus Reactivation from Dendritic Cells
- (2011) M. B. Reeves et al. JOURNAL OF VIROLOGY
- Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
- (2011) Paul D Griffiths et al. LANCET
- Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
- (2011) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Seropositivity to Cytomegalovirus, Inflammation, All-Cause and Cardiovascular Disease-Related Mortality in the United States
- (2011) Amanda M. Simanek et al. PLoS One
- The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
- (2010) A. Humar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
- (2010) T. Feuchtinger et al. BLOOD
- Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication
- (2010) Richard J. Stanton et al. JOURNAL OF CLINICAL INVESTIGATION
- Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112
- (2010) V. Prod'homme et al. JOURNAL OF GENERAL VIROLOGY
- Experimental human cytomegalovirus latency in CD14+ monocytes
- (2010) D. Hargett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications
- (2010) M. Grazia Revello et al. REVIEWS IN MEDICAL VIROLOGY
- Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
- (2008) D. J. Winston et al. BLOOD
- Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection
- (2008) D. Lilleri et al. HAEMATOLOGICA
- Cytomegalovirus seroprevalence and childhood sources of infection: A population-based study among pre-adolescents in the United States
- (2008) Stephanie A.S. Staras et al. JOURNAL OF CLINICAL VIROLOGY
- Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects
- (2008) Mary K. Wloch et al. JOURNAL OF INFECTIOUS DISEASES
- Influence of Sexual Activity on Cytomegalovirus Seroprevalence in the United States, 1988???1994
- (2008) Stephanie A.S. Staras et al. SEXUALLY TRANSMITTED DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started